Plante Moran Financial Advisors’s Definium Therapeutics DFTX Stock Holding History

Plante Moran Financial Advisors’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.69K	Hold	36	–	–	﹤0.01%	774
2026 Q1	$680	Hold	36	–	–	﹤0.01%	679
2025 Q4	$482	Hold	36	–	–	﹤0.01%	763
2025 Q3	$424	Hold	36	–	–	﹤0.01%	739
2025 Q2	$234	Hold	36	–	–	﹤0.01%	748
2025 Q1	$211	Hold	36	–	–	﹤0.01%	773
2024 Q4	$251	Hold	36	–	–	﹤0.01%	883
2024 Q3	$205	Hold	36	–	–	﹤0.01%	852
2024 Q2	$260	Hold	36	–	–	﹤0.01%	755
2024 Q1	$338	Hold	36	–	–	﹤0.01%	811
2023 Q4	$132	Hold	36	–	–	﹤0.01%	796
2023 Q3	$113	Hold	36	–	–	﹤0.01%	742
2023 Q2	$129	Hold	36	–	–	﹤0.01%	766
2023 Q1	$114	Hold	36	–	–	﹤0.01%	769
2022 Q4	$79	Hold	36	–	–	﹤0.01%	834
2022 Q3	$0	Hold	36	–	–	﹤0.01%	993
2022 Q2	$0	Buy	+36	New	+$455	﹤0.01%	1023

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Plante Moran Financial Advisors's DFTX Position: Q2 2026 in Review

Plante Moran Financial Advisors held its Definium Therapeutics (DFTX) position steady in Q2 2026 at 36 shares worth $1.69K. The position accounts for ﹤0.01% of the portfolio, ranked #774.

Plante Moran Financial Advisors first reported a position in DFTX in Q2 2022 and has held it in 17 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

Plante Moran Financial Advisors held 36 shares of Definium Therapeutics worth $1.69K as of Q2 2026.
Plante Moran Financial Advisors left its Definium Therapeutics share count unchanged in Q2 2026.
Definium Therapeutics made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #774 holding.
Plante Moran Financial Advisors first reported a position in Definium Therapeutics in Q2 2022 and has held it in 17 quarters since.
362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.